ARTICLE

STUDY OF TRENDS OF ANTIMICROBIAL RESISTANCE IN CLINICAL BACTERIAL ISOLATES FROM THREE PRIVATE TERTIARY HEALTHCARE FACILITY IN PAKISTAN

03 Pages : 30-22

http://dx.doi.org/10.31703/gdddr.2021(VI-IV).03      10.31703/gdddr.2021(VI-IV).03      Published : Dec 2021

Study of Trends of Antimicrobial Resistance in Clinical Bacterial Isolates from Three Private Tertiary Healthcare Facility in Pakistan

    Purpose of this study was to determine the prevalence of antimicrobial resistance in microbial pathogens from different clinical samples. The current study was conducted in Lahore, Faisalabad,Rawalpindi and Islamabad as these cities are ranked as highly populated cities of Pakistan. Isolation and identification of pathogens from almost 750 diverse urine, blood and pus samples by aid of selected media cultures, gram staining and various biochemical tests. Isolated pathogens were checked for antimicrobial susceptibility patterns against frequently prescribed antibiotics. In present study, Gram-negative isolates were found in maximum percentages (80 Percent) while the remaining (20 Percent) were Gram-positives. The isolate which was most recurrently recognized from Gram-positives was S. aureus and most frequently identified isolate from Gram-negative was E. coli and P. aeruginosa. The prevalence of E. coli was 20 Percent in urine, 14Percentin blood, 12Percent in stool and 4 Percent in pus. Furthermore, the resistance rate of E. coli for Streptomycin, Nalidixicacid, Ciprofloxacin, Levofloxacin, Doxycycline, Moxifloxacin, Amikacin, Gentamycin, and Amoxicillin werebetween 12 Percent to a maximum of 100Percent. Gram positive S. aureus was found considerable in urine (9Percent), bloodand pus cultures. The resistance shown by the isolates ranged from 12Percent to 100Percent against ceftriaxone,ampicillin, chloramphenicol, doxycycline, co-trimoxazole, penicillin, erythromycin, vancomycin and tetracycline. Moreover, the antibiotics like Augmentin (71Percent) and Moxifloxacin (60Percent) showed highest resistance so these are considered as poor choices for treating S. aureus infections. We concluded from this study that strict legislation and better management techniques in context to use of antimicrobial for therapeutic purposes in human and animals can minimize the chances of development of antimicrobial resistance.

    Antimicrobial Resistance, Clinical Isolates, Pathological Specimens
    (1) Alia Eum
    Faculty of Pharmacy, University of Sargodha, Punjab, Pakistan
    (2) Ume Ruqia Tulain
    Faculty of Pharmacy, University of Sargodha, Punjab, Pakistan
    (3) Nadia Shamshad Malik
    Faculty of Pharmacy, University of Sargodha, Punjab, Pakistan
    (4) Nitasha Gohar
    Faculty of Pharmacy, Capital University of Science and Technology, Islamabad, Pakistan.
    (5) Ayesha Rashid
    Department of Pharmacy, The Women University, Multan, Punjab, Pakistan
  • Touat, M., Brun-Buisson, C., Opatowski, M., Salomon, J., Guillemot, D., Tuppin, P., & Watier, L. (2021). Costs and Outcomes of 1- year post-discharge care trajectories of patients admitted with infection due to antibiotic-resistant bacteria. Journal of Infection, 82(3), 339-345.
  • World Health Organization. (2015). Antimicrobial resistance Fact sheet N°19 Updated April 2015
  • Heredia, N., & García, S. (2018). Animals as sources of food-borne pathogens: A review. Animal nutrition, 4(3), 250-255.
  • Engda, T., Moges, F., Gelaw, A., Eshete, S., & Mekonnen, F. (2018). Prevalence and antimicrobial susceptibility patterns of extended spectrum beta-lactamase producing Entrobacteriaceae in the University of Gondar Referral Hospital environments, northwest Ethiopia. BMC research notes, 11(1), 1-7.
  • Al-Balas, M., Al-Balas, H. I., Jaber, H. M., Obeidat, K., Al-Balas, H., Aborajooh, E. A., & Al-Balas, B. (2020). Distance learning in clinical medical education amid COVID-19 pandemic in Jordan: current situation, challenges, and perspectives. BMC medical education, 20(1), 1-7
  • Wani, P. A., Rafi, N., Wani, U., Bilikis A, H., & Khan, M. S. A. (2021). Simultaneous bioremediation of heavy metals and biodegradation of hydrocarbons by metal resistant Brevibacillus parabrevis OZF5 improves plant growth promotion. Bioremediation Journal, 1-12.
  • Boyanova, L. (2018). Direct Gram staining and its various benefits in the diagnosis of bacterial infections. Postgraduate medicine, 130(1), 105-110.
  • Derrick, C., Bookstaver, P. B., Lu, Z. K., Bland, C. M., King, S. T., Stover, K. R., & Justo, J. A. (2020). Multicenter, observational cohort study evaluating third-generation cephalosporin therapy for bloodstream infections secondary to Enterobacter, Serratia, and Citrobacter species. Antibiotics, 9(5), 254.
  • Buzˇn-Durßn, L., Capita, R., & Alonso-Calleja, C. (2018). Antibiotic susceptibility of methicillin-resistant staphylococci (MRS) of food origin: A comparison of agar disc diffusion method and a commercially available miniaturized test. Food microbiology, 72, 220-224.
  • Kassim, A., Omuse, G., Premji, Z., & Revathi, G. (2016). Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross- sectional study. Annals of clinical microbiology and antimicrobials, 15(1), 1-7.
  • Vanstokstraeten, R., Belasri, N., Demuyser, T., Crombé, F., Barbé, K., & Piérard, D. (2021). A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines. European Journal of Clinical Microbiology & Infectious Diseases, 40(11), 2371-2377.
  • Antonoplis, A., Zang, X., Wegner, T., Wender, P. A., & Cegelski, L. (2019). Vancomycin- arginine conjugate inhibits growth of carbapenem-resistant E. coli and targets cell- wall synthesis. ACS chemical biology, 14(9), 2065-2070.
  • Wang, S. S., Ratliff, P. D., & Judd, W. R. (2018). Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections. International Journal of Clinical Pharmacy, 40(1), 143-149
  • Abebe, M., Tadesse, S., Meseret, G., & Derbie, A. (2019). Type of bacterial isolates and antimicrobial resistance profile from different clinical samples at a Referral Hospital, Northwest Ethiopia: five years data analysis. BMC research notes, 12(1), 1-6
  • Nguyen, L., Garcia, J., Gruenberg, K., & MacDougall, C. (2018). Multidrug-resistant Pseudomonas infections: hard to treat, but hope on the horizon?. Current infectious disease reports, 20(8), 1-10.
  • Bowen, A. C., Carapetis, J. R., Currie, B. J., Fowler Jr, V., Chambers, H. F., & Tong, S. Y. (2017). Sulfamethoxazole-trimethoprim (cotrimoxazole) for skin and soft tissue infections including impetigo, cellulitis, and abscess. In Open forum infectious diseases 4(4), p. ofx232). US: Oxford University Press.
  • Verma, A. K., Bauer, C., Yajjala, V. K., Bansal, S., & Sun, K. (2019). Linezolid attenuates lethal lung damage during postinfluenza methicillin-resistant Staphylococcus aureus pneumonia. Infection and immunity, 87(10), e00538-19.
  • Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015). Antimicrobial resistance: a global multifaceted phenomenon. Pathogens and global health, 109(7), 309-318
  • Axente, C., Licker, M., Moldovan, R., Hogea, E., Muntean, D., Horhat, F., & Baditoiu, L. (2017). Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit. BMC infectious diseases, 17(1), 1-9.
  • Faizullah, M., Umar, M. I., Anwar, M., & Sarfraz, M. K. (2017). A cross-sectional study on knowledge, attitude and practices of medical doctors towards antibiotic prescribing patterns and resistance in Khyber Pakhtun Khawah, Pakistan.
  • Farah, S. M., Alshehri, M. A., Alfawaz, T. S., Alasmeri, F. A., Alageel, A. A., & Alshahrani, D. A. (2019). Trends in antimicrobial susceptibility patterns in King Fahad Medical City, Riyadh, Saudi Arabia. Saudi medical journal, 40(3), 252.

Cite this article

    APA : Eum, A., Tulain, U. R., & Malik, N. S. (2021). Study of Trends of Antimicrobial Resistance in Clinical Bacterial Isolates from Three Private Tertiary Healthcare Facility in Pakistan. Global Drug Design & Development Review, VI(IV), 30-22. https://doi.org/10.31703/gdddr.2021(VI-IV).03
    CHICAGO : Eum, Alia, Ume Ruqia Tulain, and Nadia Shamshad Malik. 2021. "Study of Trends of Antimicrobial Resistance in Clinical Bacterial Isolates from Three Private Tertiary Healthcare Facility in Pakistan." Global Drug Design & Development Review, VI (IV): 30-22 doi: 10.31703/gdddr.2021(VI-IV).03
    HARVARD : EUM, A., TULAIN, U. R. & MALIK, N. S. 2021. Study of Trends of Antimicrobial Resistance in Clinical Bacterial Isolates from Three Private Tertiary Healthcare Facility in Pakistan. Global Drug Design & Development Review, VI, 30-22.
    MHRA : Eum, Alia, Ume Ruqia Tulain, and Nadia Shamshad Malik. 2021. "Study of Trends of Antimicrobial Resistance in Clinical Bacterial Isolates from Three Private Tertiary Healthcare Facility in Pakistan." Global Drug Design & Development Review, VI: 30-22
    MLA : Eum, Alia, Ume Ruqia Tulain, and Nadia Shamshad Malik. "Study of Trends of Antimicrobial Resistance in Clinical Bacterial Isolates from Three Private Tertiary Healthcare Facility in Pakistan." Global Drug Design & Development Review, VI.IV (2021): 30-22 Print.
    OXFORD : Eum, Alia, Tulain, Ume Ruqia, and Malik, Nadia Shamshad (2021), "Study of Trends of Antimicrobial Resistance in Clinical Bacterial Isolates from Three Private Tertiary Healthcare Facility in Pakistan", Global Drug Design & Development Review, VI (IV), 30-22
    TURABIAN : Eum, Alia, Ume Ruqia Tulain, and Nadia Shamshad Malik. "Study of Trends of Antimicrobial Resistance in Clinical Bacterial Isolates from Three Private Tertiary Healthcare Facility in Pakistan." Global Drug Design & Development Review VI, no. IV (2021): 30-22. https://doi.org/10.31703/gdddr.2021(VI-IV).03